placeholder image
C. B. Morse All authors
About
Publications While At HealthPartners
Highlights
selected publications
Journal Article
  • Comparing Durvalumab, Olaparib, and Cediranib monotherapy, combination therapy, or chemotherapy in patients with platinum-resistant ovarian cancer with prior Bevacizumab: the phase II NRG-GY023 trial. 
    Clinical Cancer Research. 2025
    • Contact
    full name
  • C. B. Morse
    • Quick Info
    Publications
    Publications in the past 10 years based solely on publications while at HealthPartners. Publications in prior years appear in grey.
    Collaboration